Metraipolis › archive › dc_cd1610039532

First-in-human to proof-of-concept: why experimental medicine studies remain essential in human physiology and drug development — Europe PMC PMID:42240850

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42240850
DOI
10.1007/s00424-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-31T19:19:25.333Z
SHA-256 of the archived text
74242f455d6e101a5f5c27136063a4a3ab2a3d841a81a0f70450852b39cbfd17
Stable URL of this page
https://metraipolis.com/documento/dc_cd1610039532

How to cite

First-in-human to proof-of-concept: why experimental medicine studies remain essential in human physiology and drug development — Europe PMC PMID:42240850 — Europe PMC (en), https://europepmc.org/article/MED/42240850 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd1610039532 (Metraipolis archive dc_cd1610039532, sha256 74242f455d6e101a5f5c27136063a4a3ab2a3d841a81a0f70450852b39cbfd17)
BibTeX
@misc{dccd1610039532,
  title = {First-in-human to proof-of-concept: why experimental medicine studies remain essential in human physiology and drug development — Europe PMC PMID:42240850},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42240850},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd1610039532; sha256 74242f455d6e101a5f5c27136063a4a3ab2a3d841a81a0f70450852b39cbfd17},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42240850. Agents can read the archived copy with the MCP tool read_document.